• 主页
  • 查找结果
  • Refined biokinetic model for humans exposed to cobalt dietary supplements and other sources of systemic cobalt exposure.

Refined biokinetic model for humans exposed to cobalt dietary supplements and other sources of systemic cobalt exposure.

Chemico-biological interactions (2014-04-15)
Kenneth M Unice, Brent D Kerger, Dennis J Paustenbach, Brent L Finley, Brooke E Tvermoes
摘要

An updated biokinetic model for human exposures to cobalt (Co) was developed based on a comprehensive set of human pharmacokinetics data collected from five male and five female volunteers who ingested ∼1 mg Co/day of a Co supplement for 3 months. Three key experimental observations from the human dosing studies were incorporated into the model: (1) an increase in the measured fraction of large molecular serum protein bound Co from 95% during dosing to 99% after dosing; (2) a linear decrease in Co red blood cell concentration after dosing; and (3) Co renal clearance consistent with estimated glomerular filtration rates and free Co²⁺ concentration. The model was refined by adding compartments accounting for (1) albumin bound Co in intravascular fluid (serum); (2) albumin bound Co in extravascular fluid with physiologic exchange rates of albumin bound Co between extravascular and intravascular fluid; and (3) a novel sequential cascade of compartments representing red blood cell ages between 1 and 120 days. Reasonable agreement between the modeled and measured urine, serum, and whole blood concentrations were observed (r>0.84, slope=0.79-1.0) with gastrointestinal absorption rates between 9% and 66%. In addition, model predictions agreed well with data from several external studies representing healthy human volunteers, dialysis patients, anephric patients, a Co-poisoning incident and whole body retention studies. Our revised model considerably improves the state of knowledge on human Co kinetics, and should be helpful for evaluating elevated blood Co concentrations in currently exposed populations, such as metal-on-metal (MoM) hip implant patients.

材料
货号
品牌
产品描述

Sigma-Aldrich
钴, powder, 2 μm particle size, 99.8% trace metals basis
Sigma-Aldrich
钴, powder, <150 μm, ≥99.9% trace metals basis
Sigma-Aldrich
钴, Carbon coated magnetic, nanopowder, <50 nm particle size (TEM), ≥99%
Sigma-Aldrich
钴, granular, 99.99% trace metals basis
Sigma-Aldrich
钴, foil, thickness 0.1 mm, 99.95% trace metals basis
Sigma-Aldrich
钴, pieces, 99.5% trace metals basis
Sigma-Aldrich
钴, foil, thickness 1.0 mm, 99.95% trace metals basis
Sigma-Aldrich
钴, rod, diam. 5.0 mm, 99.95% trace metals basis
钴, foil, 25mm disks, thickness 0.05mm, annealed, 99.9%
钴, foil, 25mm disks, thickness 0.05mm, as rolled, 99.9%
钴, foil, 25mm disks, thickness 0.125mm, annealed, 99.9%
钴, foil, 25mm disks, thickness 0.25mm, as rolled, 99.9%
钴, foil, 25mm disks, thickness 0.25mm, as rolled, 99.99+%
钴, foil, 4mm disks, thickness 0.003mm, 99.9%
钴, foil, 4mm disks, thickness 0.004mm, 99.9%
钴, foil, 4mm disks, thickness 0.005mm, 99.9%
钴, foil, 4mm disks, thickness 0.006mm, 99.9%
钴, foil, 4mm disks, thickness 0.007mm, 99.9%
钴, foil, 4mm disks, thickness 0.008mm, 99.9%
钴, foil, 4mm disks, thickness 0.009mm, 99.9%
钴, foil, 4mm disks, thickness 0.0125mm, 99.9%
钴, foil, 4mm disks, thickness 0.015mm, 99.9%
钴, foil, 4mm disks, thickness 0.01mm, 99.9%
钴, foil, 4mm disks, thickness 0.025mm, 99.9%
钴, foil, 4mm disks, thickness 0.02mm, 99.9%
钴, foil, 4mm disks, thickness 0.05mm, annealed, 99.9%
钴, foil, 4mm disks, thickness 0.05mm, as rolled, 99.9%
钴, foil, 4mm disks, thickness 0.05mm, as rolled, 99.99+%
钴, foil, 4mm disks, thickness 0.125mm, annealed, 99.9%
钴, foil, 4mm disks, thickness 0.125mm, as rolled, 99.99+%

社交媒体

LinkedIn icon
Twitter icon
Facebook Icon
Instagram Icon

Merck

科研、开发、生产。

作为生命科学行业的全球领先供应商,我们致力于为科研、生物技术开发和生产,以及制药药物疗法开发和生产提供各类解决方案和服务。

© 2021年版权归德国达姆施塔特默克集团(Merck KGaA)及/或其附属公司所有。版权所有。

未经许可,严禁复制本网站上的任何资料。